These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30963332)

  • 1. Ranolazine: impact on quality of life in patients with stable angina pectoris, results from an observational study in Austria - the ARETHA AT study.
    Zweiker R; Aichinger J; Metzler B; Lang I; Wallner E; Delle-Karth G
    Wien Klin Wochenschr; 2019 Apr; 131(7-8):165-173. PubMed ID: 30963332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ranolazine reduces angina frequency and severity and improves quality of life: Observational study in patients with chronic angina under ranolazine treatment in Greece (OSCAR-GR).
    Alexopoulos D; Kochiadakis G; Afthonidis D; Barbetseas J; Kelembekoglou P; Limberi S; Spanos A; Triantafyllidis G
    Int J Cardiol; 2016 Feb; 205():111-116. PubMed ID: 26730841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and Tolerability of Ivabradine with or Without Concomitant Beta-Blocker Therapy in Patients with Chronic Stable Angina in Routine Clinical Practice.
    Perings S; Stöckl G; Kelm M;
    Adv Ther; 2016 Sep; 33(9):1550-64. PubMed ID: 27432382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ivabradine in combination with beta-blocker reduces symptoms and improves quality of life in elderly patients with stable angina pectoris: age-related results from the ADDITIONS study.
    Müller-Werdan U; Stöckl G; Ebelt H; Nuding S; Höpfner F; Werdan K;
    Exp Gerontol; 2014 Nov; 59():34-41. PubMed ID: 25193811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-World Data from the Use of Ranolazine in Patients with Stable Angina Pectoris: The RANGER Study.
    Olympios C; Stafylas P; Dermitzakis A; Efthimiadis I; Gardikiotis A; Kakouros S; Lampropoulos S; Barbetseas J; Sourgounis A; On Behalf Of Ranger Investigators
    J Clin Med; 2024 Mar; 13(6):. PubMed ID: 38541898
    [No Abstract]   [Full Text] [Related]  

  • 6. Ivabradine in combination with beta-blocker improves symptoms and quality of life in patients with stable angina pectoris: results from the ADDITIONS study.
    Werdan K; Ebelt H; Nuding S; Höpfner F; Hack G; Müller-Werdan U
    Clin Res Cardiol; 2012 May; 101(5):365-73. PubMed ID: 22231643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ranolazine on exercise tolerance and angina frequency in patients with severe chronic angina receiving maximally-tolerated background therapy: analysis from the Combination Assessment of Ranolazine In Stable Angina (CARISA) randomized trial.
    Sendón JL; Lee S; Cheng ML; Ben-Yehuda O;
    Eur J Prev Cardiol; 2012 Oct; 19(5):952-9. PubMed ID: 22689417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and Economic Outcomes of Ranolazine Versus Conventional Antianginals Users Among Veterans With Chronic Stable Angina Pectoris.
    Bress AP; Dodson JA; King JB; Sauer BC; Reese T; Crook J; Radwanski P; Knippenberg K; Greene T; Nelson RE; Munger MA; Weintraub WS; LaFleur J
    Am J Cardiol; 2018 Dec; 122(11):1809-1816. PubMed ID: 30292334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effectiveness of Trimetazidine Treatment in Patients with Stable Angina Pectoris of Various Durations: Results from the CHOICE-2 Study.
    Glezer M;
    Adv Ther; 2018 Jul; 35(7):1103-1113. PubMed ID: 29766461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of ranolazine on clinical outcomes and healthcare resource utilization in patients with refractory angina pectoris.
    Ling H; Packard KA; Burns TL; Hilleman DE
    Am J Cardiovasc Drugs; 2013 Dec; 13(6):407-12. PubMed ID: 23873327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ranolazine reduces patient-reported angina severity and frequency and improves quality of life in selected patients with chronic angina.
    Muhlestein JB; Grehan S
    Drugs R D; 2013 Sep; 13(3):207-13. PubMed ID: 23990357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ranolazine for the treatment of refractory angina in a veterans population.
    Greene RS; Rangel RM; Edwards KL; Chastain LM; Brouse SD; Alvarez CA; Collins LJ; Brilakis ES; Banerjee S
    Cardiovasc Revasc Med; 2012; 13(2):141.e1-5. PubMed ID: 21856249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Effectiveness of Ranolazine Versus Traditional Therapies in Chronic Stable Angina Pectoris and Concomitant Diabetes Mellitus and Impact on Health Care Resource Utilization and Cardiac Interventions.
    Page RL; Ghushchyan V; Read RA; Hartsfield CL; Koch BR; Nair KV
    Am J Cardiol; 2015 Nov; 116(9):1321-8. PubMed ID: 26358510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Exercise Training With and Without Ranolazine on Peak Oxygen Consumption, Daily Physical Activity, and Quality of Life in Patients With Chronic Stable Angina Pectoris.
    Willis LH; Slentz CA; Johnson JL; Kelly LS; Craig KP; Hoselton AL; Kraus WE
    Am J Cardiol; 2019 Sep; 124(5):655-660. PubMed ID: 31296368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial.
    Stone PH; Gratsiansky NA; Blokhin A; Huang IZ; Meng L;
    J Am Coll Cardiol; 2006 Aug; 48(3):566-75. PubMed ID: 16875985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with ranolazine in a veteran population with chronic stable angina.
    Reeder DN; Gillette MA; Franck AJ; Frohnapple DJ
    Ann Pharmacother; 2012 Jan; 46(1):42-50. PubMed ID: 22215689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The usefulness of ranolazine for the treatment of refractory chronic stable angina pectoris as determined from a systematic review of randomized controlled trials.
    Banon D; Filion KB; Budlovsky T; Franck C; Eisenberg MJ
    Am J Cardiol; 2014 Mar; 113(6):1075-82. PubMed ID: 24462341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ranolazine in treatment of stable angina in woman with atrial fibrillation and intermittent left bundle branch block - a case report.
    Yuriivna Osovska N; Vitaliivna Kuzminova N
    Pol Merkur Lekarski; 2016 Dec; 41(246):287-292. PubMed ID: 28024133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ranolazine for the treatment of chronic stable angina: a cost-effectiveness analysis from the UK perspective.
    Coleman CI; Freemantle N; Kohn CG
    BMJ Open; 2015 Nov; 5(11):e008861. PubMed ID: 26546142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.